This site is intended for customers outside the United States. | Switch to: United States
Return Home
Indications and Important Safety Information
Visit Abbott Medical Optics
nav_patient nav_physician

Product Overviews


Text Size: SM / MD / LG

THE NEW TECNIS® 1-PIECE IOL PROVIDES THE UNMATCHED BENEFITS OF TECNIS® TECHNOLOGY IN A NEXT-GENERATION ONE-PIECE DESIGN

OPTICS:
The first and only FDA-approved wavefront-designed optic that rejuvenates vision by correcting spherical aberration to essentially zero.

MATERIAL:
The proprietary hydrophobic acrylic material with the lowest chromatic aberration and highest optical throughput transmits healthy blue light and reduces the incidence of glistenings.

DESIGN:
The only one-piece lens with the performance of a ProTEC 360° barrier edge, the stability of Tri-Fix 3-point design, and a frosted edge treatment.

ADVANCED TECHNOLOGIES THAT CREATE OPTICAL SYNERGY

Optical Synergy

This proprietary combination of optic, material, and design technologies work together to create Optical Synergy for superior visual results.

View the Optical Synergy Interactive Module

TECNIS® 1-PIECE IOL

TECNIS 1-Piece IOL
TECNIS 1-Piece IOL Specs

For more information, contact your AMO representative or call 1-877-AMO-4-LIFE

1. Value theoretically derived for a typical 20.0 D lens. AMO recommends that surgeons personalize their A-constant based on their surgical techniques and equipment, experience with the lens model, and post-operative results.

2. Calculated based on Holladay I formula (Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988;14(1):17-24).

Indications and Important Safety Information

TECNIS® IOLs

Caution

Federal law restricts this device to sale by or on the order of a physician.

Indications

TECNIS® lenses are indicated for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by extracapsular cataract extraction. These devices are intended to be placed in the capsular bag.

Warnings

Physicians considering lens implantation under any of the conditions described in the Directions for Use labeling should weigh the potential risk/benefit ratio prior to implanting a lens.

Precautions

Do not resterilize or autoclave. Use only sterile irrigating solutions such as balanced salt solution or sterile normal saline. Do not store in direct sunlight or over 45°C.

Adverse Events

Adverse events occurred at rates between 1.6% and 3.3% during the clinical trials for TECNIS® IOLs or their “parent” IOLs. These events included macular edema, endophthalmitis, anterior lens tissue ongrowth, lens dislocation, hypopyon, corneal edema, iritis, hyphema, secondary glaucoma, and secondary surgical intervention. 

Attention

Reference the Directions for Use for a complete listing of indications, warnings, and precautions.

Back to Top of Page

LegalPrivacy PolicyTerms of Use